Keywords: Pandemic, COVID-19, SARS-Cov-2, anti-epidemic protection


Introduction. The new COVID-19 pandemic has become a new challenge for all countries in the world, requiring adequate anti-epidemic protection of populations and territories with the purpose to reduce medical, economic, political and other losses due to the rapid spread of the SARS-Cov-2 pathogen. Systems of preparedness and response to biological threats are significantly different at national levels, which has essentially influence at possibility of timely assessment of unusual event and minimization of multiple losses.

The aim of the work was to compare epidemiologically important markers of pandemic course, to evaluate different pandemic’ response tactics in the dynamics of events on different WHO regions.

Methods. Analytical method of complex epidemiological method was used to evaluate of pandemic trends; dynamics and trends were determined according to WHO, euroCDC, CDC (Atlanta, USA), MoH of Ukraine and other online resources.

Results. The rapid spread of the novel coronavirus SARS-Cov-2 has been facilitated by globalization processes, and the delaying of WHO's declared the coronavirus outbreak a Global Public Health Emergency; non-compliance with restrictions on tourist and other migration processes of the population and goods from / to the affected regions. Early contracted the virus as a new pathogenic biological agent with a high epidemic potential has contributed to significant advances in the study of the epidemiological, clinical features of COVID-19, choices of treatment tactics and anti-epidemic measures.

Conclusion. The development of the COVID-19 pandemic was determined by the capacity of national biological threat response systems, the chosen tactics of anti-epidemic protection systems in accordance with the states capacity and the stage of emergency situations in the dynamics of the pandemic in temporal and spatial characteristics.


Download data is not yet available.


China CDC has Detected Novel Coronavirus in Southern China Seafood Market of Wuhan. (in Chinese) (2020-01-27)[2020-03-15].

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z. 2020. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. Published online February 7, 2020.

Chan JF, Yuan S, Kok K, To, K.K., Chu, H., Yang, J., Xing, F., Liu, J. 2020. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. Published online January 24, 2020.

Li Q, Guan X, Wu P, Zhou L, Tong Y, Ren R, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus−infected pneumonia. N Engl J Med. 2020.

Chinese Center for Disease Control and Prevention. Guidelines for Epidemiological Investigation of COVID19. (in Chinese) (2020-03-09)[2020-03-15].

Ren LL, Wang YM, Wu YQ, Xiang YC, Guo L, Xu T, Jiang, Y.Z., Xiong, Y., Li, Y.J., Li, X.W., Li, H., Fan, G.H., Gu, X.Y., Xiao, Y., Gao, H., Xu, J.Y., Yang, F., Wang, X.M., Wu, C., Chen, L., Liu, Y.W., Liu, B., Yang, J., Wang, X.R., Dong, J., Li, L., Huang, C.L., Zhao, J.P., Hu, Y., Cheng, Z.S., Liu, L.L., Qian, Z.H., Qin, C., Jin, Q., Cao, B., Wang, J.W. 2020. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020.

Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. Published online January 29, 2020.

Wang, C., Horby, P,, Hayden, F., Gao, G. A novel coronavirus outbreak of global health concern. The Lancet. Published online January 24, 2020.

Chinese Center for Disease Control and Prevention. Guidelines for Investigation and Management of Close Contacts of COVID-19 Patients. (in Chinese) (2020-03-09)[2020-03-15].

Chinese Center for Disease Control and Prevention. Technical Guidelines for Disinfection of Special Sites. (in Chinse) (2020-03-09)[2020-03-15].

To, K.K., Tsang, O.T.Y., Chik-Yan, Yip. C., Chan, K.H., Wu, T.C., Chan, J.M.C., Leung, W.S., Chik, T.S., Choi, C.Y., Kandamby, D.H., Lung, D.C., Tam, A.R., Poon, R.W., Fung, A.Y., Hung, I.F., Cheng, V.C., Chan, J.F., Yuen, K.Y. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases. Published online February 12, 2020.

Huijun C, Guo, J, Wang, C, Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., Liao J., Yang, H., Hou, W., Zhang, Y. 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. Published online February 12, 2020.

Zhu, H., Wang, L., Fang, CL., Peng, S., Zhang, L., Chang, G., Xia, S., Zhou, W. 2020. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl. Pediatr., 9(1): 51-60.

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. February 6, 2020. pii: S0195-6701(20)30046-3.

Kickbusch, I. and G. Leung, Response to the emerging novel coronavirus outbreak. BMJ, 2020. 368: p. m406.

Huang C, Wang Y, Li X, Ren L, Yhao J, Hu Y, Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J., Cao, B. 2020. Clinical features of patients infected with 2019 coronavirus in Wuhan, China. Lancet. 2020. doi:10.1016/S0140-6736(20)30183-5.

National Health Commission and National Administration of Traditional Chinese Medicine of the People's Republic of China. Protocols for Diagnosis and Treatment of COVID-19 (7th Trial Version). (202003-04) [2020-03-15]. (in Chinese)

National Health Commission of the People's Republic of China. Protocols for Prevention and Control of COVID-19 (6th Version).(2020-03-09)[2020-03-15]. (in Chinese)

WHO, 2019. Health Emergency and Disaster Risk Management Framework, WHO: Geneva.

2019 Novel Coronavirus (2019-nCoV): Strategic Preparedness and Response Plan.

WHO, 2016. Guidance for Managing Ethical Issues in Infectious Disease Outbreaks. 2016, WHO: Geneva, Switzerland. /WHO-2019-nCoV-SurveillanceGuidance-2020.3eng.pdf

WHO. International Health Regulation.

WHO. How to put on and take off personal protective equipment (PPE). Geneva: WHO; 2008 ( putontakeoffPPE/en/

Chinese Center for Disease Control and Prevention. Guidelines for Personal Protection of Specific Groups. (in Chinese) (2020-03-09)[2020-03-15]. csr/disease/coronavirus_infections/case-management/eng

Pachetti M, Marins Br, Beneditti Fr, Giudici F, Mauro El, Storici P, Masciovecchio, Angeletti S, Ciccozzi M, Gallo R Ch, Zella D, Ippodrino R. Emerging SARS-Cov-2 mutation hot spots include a novel RNA-dependent_RNA polymerase variant J. Translation medicine.

WHO, 2020. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance January 2020. Geneva:

Chinese Center for Disease Control and Prevention. Technical Guidelines for COVID-19 Laboratory Testing. (in Chinese) (2020-03-09)[2020-03-15].

Abstract views: 141
PDF Downloads: 119
How to Cite
Vynograd N. COVID-2019 PANDEMIC: EPIDEMIOLOGICAL ASPECTS. Proc Shevchenko Sci Soc Med Sci [Internet]. 2020Apr.14 [cited 2021Oct.26];59(1). Available from: